Neuroscience and Behavioral Physiology

, Volume 38, Issue 3, pp 259–267 | Cite as

Neurophysiological characteristics of cognitive functions in patients with first episodes of endogenous psychosis

  • I. S. Lebedeva
  • V. G. Kaleda
  • A. N. Barkhatova


This report presents studies of the neurophysiological correlates of the characteristics of cognitive disorders in patients with first psychotic episodes of endogenous psychosis at juvenile age. Three groups of patients were studied: those with a predominance of catatonic symptomatology (22 patients), those with a predominance of hallucinatory-delusional symptomatology (22 patients), and those with a predominance of affective-delusional symptomatology (24 patients), along with a group of psychologically healthy subjects (15 subjects). Parameters of auditory evoked potentials were analyzed using the oddball paradigm. The group with a predominance of catatonic disorders showed the greatest differences in the latent periods (LP) of the N200 and P300 components as compared with the other groups; patients with a predominance of hallucinatory-delusional symptomatology showed the most localized anomalies in the latent period of the P300 component; the group of patients dominated by affective-delusional symptomatology showed almost no increase in the latent period of the N200 component, though the extents of anomalies in the N100 component in responses to non-target signals and deviations in the P300 component were more marked than in the other groups. These characteristics of the neurophysiological correlates of cognitive functions in each group of patients supported the significance of evaluating the psychopathological structure of manifest psychotic episodes for determining the clinical typology.

Key Words

auditory evoked potentials P300 N200 first episode endogenous psychosis juvenile age hallucinatory-delusional disorders catatonic disorders affective-delusional disorders 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    L. V. Androsova and V. G. Kaleda, “Cytokines and their soluble receptors in the serum of patients with schizoaffective disorders: relationship to clinical parameters,” in: Affective and Schizoaffective Disorders [in Russian], Moscow (2003), pp. 225–226.Google Scholar
  2. 2.
    A. N. Barkhatova, Endogenous Juvenile Seizure-Like Psychosis with Catatonic Disorders in the Structure of Manifest Attacks [in Russian], Author’s Abstract of Doctoral Thesis in Medical Sciences, Moscow (2005).Google Scholar
  3. 3.
    M. Sh. Vrono, “Age-related aspects of the study of schizophrenia in children and adolescents,” Zh. Nevropatol. Psikhiat., 80, No. 10, 1510–1514 (1980).Google Scholar
  4. 4.
    I. Ya. Gurovich, A. B. Shmukler, E. B. Lyubov, et al., Clinical Features of First Psychotic Episodes (Day Hospital or Clinics Designed for Patients with First Episodes of Schizophrenia). Methodological Recommendations [in Russian], Moscow (2003).Google Scholar
  5. 5.
    V. G. Kaleda, “Treatment of endogenous seizure-like psychoses in juveniles — basic principles and approaches,” Zh. Nevrol. Psikhiat., 106, No. 9, 4–11 (2006).Google Scholar
  6. 6.
    V. G. Kaleda and A. N. Barkhatova, “Characteristics of cognitive disorders at the stage of establishment of remission after episodes of endogenous seizure-like psychosis in adolescents,” in: Proceedings of the Third International Congress ‘The Young Generation of the XXI Century. Current Problems of Social-Psychological Health [in Russian], Moscow (2006), pp. 273–274.Google Scholar
  7. 7.
    V. G. Kritskaya and T. K. Meleshko, “Experimental psychological studies of endogenous psychoses in adolescents,” Psikhiatriya, 5, 41–45 (2003).Google Scholar
  8. 8.
    M. V. Magomedova, Relationship between Social Functioning and Neurocognitive Deficit in Patients with Schizophrenia and Schizoaffective Disorders at the Early and Late Stages of Disease [in Russian], Author’s Abstract of Doctoral Thesis in Medical Sciences, Moscow (2003).Google Scholar
  9. 9.
    L. G. Movina, Psychosocial Therapy of Patients with Schizophrenia and Disorders of the Schizophrenic Spectrum with First Psychotic Episodes [in Russian], Author’s Abstract of Doctoral Thesis in Medical Sciences, Moscow (2005).Google Scholar
  10. 10.
    R. A. Nadzharov and É. Ya. Shternberg, “Age-related clinical features and course of schizophrenia,” Zh. Nevropatol. Psikhiatr., 75, No. 9, 1374–1379 (1975).PubMedGoogle Scholar
  11. 11.
    M. A. Sidorova, V. G. Kaleda, and A. N. Barkhatova, “Characteristics of neurocognitive disorders in patients with shizoaffective psychosis and seizure-like schizophrenia at adolescent age,” Psikhiatriya, 6, 15–21 (2004).Google Scholar
  12. 12.
    A. B. Smulevich, “Non-manifest types of schizophrenia — psychopathology and treatment,” Zh. Nevropatol. Psikhiat., 105, No. 5, 4–10 (2005).Google Scholar
  13. 13.
    Ya. A. Storozhakova and O. E. Kholodova, “First psychotic episodes: clinical-social and organizational aspects,” Sots. Klin. Psikhiat., 10, No. 2, 74–80 (2000).Google Scholar
  14. 14.
    A. S. Titanov, “Clinical psychiatry and problems in the study of new psychopharmacological agents,” Zh. Nevrol. Psikhiat., 102, No. 10, 3–6 (2002).Google Scholar
  15. 15.
    M. Ya. Tsutsul’kovskaya and G. P. Panteleeva, “Clinical features and differential assessment of psychopathological syndromes at pubertal age,” in: Questions of Schizophrenia in Children and Adolescents [in Russian], Moscow (1986), pp. 13–28.Google Scholar
  16. 16.
    M. Ya. Tsutsul’kovskaya and V. G. Kaleda, “Clinical features of the course and outcome of schizoaffective psychosis manifest at juvenile age,” in: Affective and Schizoaffective Psychoses [in Russian], Moscow (1998), pp. 156–168.Google Scholar
  17. 17.
    M. Ya. Tsutsul’kovskaya, V. G. Kaleda, I. V. Oleichik, et al., “Psychoendocrine characteristics a juvenile age and their role in the specific features of the psychotropic therapy of endogenous mental disorders,” in: Proceedings of the All-Russian Scientific-Applied Conference in Memory of Professor A. I. Belkin [in Russian], Moscow (2004), pp. 114–116.Google Scholar
  18. 18.
    L. M. Shmaonova and Yu. I. Liberman, “Some characteristics of the course of seizure-like schizophrenia,” Zh. Nevropatol. Psikhiat., 79, No. 6, 770–779 (1979).Google Scholar
  19. 19.
    R. M. Bilder, R. S. Goldman, D. Robinson, et al., “Neuropsychology of first episode schizophrenia: initial characterization and clinical correlates,” Amer. J. Psychiat., 157, 549–559 (2000).PubMedCrossRefGoogle Scholar
  20. 20.
    N. Boutros, H. Nasrallah, R. Leighty, et al., “Auditory evoked potentials, clinical vs research applications,” Psychiat. Res., 69, 183–195 (1997).CrossRefGoogle Scholar
  21. 21.
    K. Brown, C. Gonsalvez, and A. Harris, “Target and non-target ERP disturbances in first episode vs chronic schizophrenia,” Clin. Neurophysiol., 113, No. 11, 1754–1763 (2002).PubMedCrossRefGoogle Scholar
  22. 22.
    M. Caliguri, J. Hellige, B. Cherry, et al., “Lateralized cognitive dysfunction and psychotic symptoms in schizophrenia,” Schizophrenia Res., 80, No. 2–3, 151–161 (2005).CrossRefGoogle Scholar
  23. 23.
    A. Clark, “Proposed treatment for adolescent psychosis. 1: Schizophrenia and schizophrenia-like psychoses,” in: Advances in Psychiatric Treatment (2001), Vol. 7, pp. 16–23.CrossRefGoogle Scholar
  24. 24.
    J. Cummings, “Neuropsychiatric manifestations of right-hemisphere lesions,” Brain Lang., 57, 22–37 (1997).PubMedCrossRefGoogle Scholar
  25. 25.
    M. Davidson, A. Caspi, and S. Noy, “The treatment of schizophrenia: from premorbid manifestations to the first episode of psychosis,” in: Dialogues in Clinical Neuroscience. Early Stages of Schizophrenia (2005), Vol. 7, No. 1, pp. 7–16.Google Scholar
  26. 26.
    W. W. Fleischhacker, “Treatment of first-episode schizophrenia,” Eur. Psychiat., 17, Supplement 4, 371–375 (2002).CrossRefGoogle Scholar
  27. 27.
    R. Freedman, R. Ross, S. Leonard, et al., “Early biomarkers of psychosis,” Dialogues in Clinical Neuroscience. Early Stages of Schizophrenia (2005), Vol. 7, No. 1, pp. 17–30.Google Scholar
  28. 28.
    L. Garcia-Larrea, A. C. Lukaszewicz, and F. Mauguiere, “Revisiting the oddball paradigm. Non-target vs. neutral stimuli and the evaluation of ERP attentional effects,” Neuropsychologia, 30, No. 8, 723–741 (1992).PubMedCrossRefGoogle Scholar
  29. 29.
    M. F. Green, K. H. Nuechterlien, J. M. Gold, et al., “Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria,” Biol. Psychiat., 56, 301–307 (2004).PubMedCrossRefGoogle Scholar
  30. 30.
    M. Harris, L. Henry, S. Harrigan, et al., “The relationship between duration of untreated psychosis and outcome: an eight-year prospective study,” Schizophrenia Res., 79, No. 1, 85–93 (2005).CrossRefGoogle Scholar
  31. 31.
    D. Hemsley, “The development of a cognitive model of schizophrenia: placing it in context,” Neurosci. Biobehav. Rev., 29, 977–988 (2005).PubMedCrossRefGoogle Scholar
  32. 32.
    M. Keshavan, V. Diwadkar, D. Montrose, et al., “Premorbid indicators and risk for schizophrenia: a selective review and update,” Schizophrenia Res., 79, No. 1, 45–59 (2005).CrossRefGoogle Scholar
  33. 33.
    C. Kessier and A. Steinberg, “Evoked potential variation in schizophrenic subgroups,” Biol. Psychiat., 26, No. 4, 372–380 (1989).CrossRefGoogle Scholar
  34. 34.
    D. M. Kipke et al., Adolescent Development and the Biology of Puberty: Summary of a Workshop on New Research, Washington (1999).Google Scholar
  35. 35.
    A. F. Kramer and D. L. Strayer, “Assessing the development of automatic processing: an application of dual-task and event-related brain potential methodologies,” Biol. Psychol., 26, No. 1–3, 231–267 (1988).PubMedCrossRefGoogle Scholar
  36. 36.
    A. K. Malla, R. M. Taylor, J. Takhar, et al., “Can patients at risk for persistent negative symptoms be indemnified during their first episode of psychosis?” J. Nerv. Ment. Dis., 192, No. 7, 455–463 (2004).PubMedCrossRefGoogle Scholar
  37. 37.
    J. F. Masterson, “Psychiatric significance of adolescent turmoil,” Amer. J. Psychiat., 124, 1549–1554 (1968).PubMedGoogle Scholar
  38. 38.
    D. Mathalon, J. Ford, and A. Pfefferbaum, “Trait and state aspects of P300 amplitude reduction in schizophrenia: a retrospective longitudinal study,” Biol. Psychiat., 47, No. 5, 434–449 (2000).PubMedCrossRefGoogle Scholar
  39. 39.
    G. McCarthy and F. Donchin, “A metric for thought: a comparison of P300 latency and reaction time,” Science, 211, No. 4477, 77–80 (1981).PubMedCrossRefGoogle Scholar
  40. 40.
    C. McKay, D. Heallam, and D. Copolov, “Central auditory processing in patients with auditory hallucinations,” Amer. J. Psychiat., 157, 759–766 (2000).PubMedCrossRefGoogle Scholar
  41. 41.
    P. Milev, B. Ho, S. Arndt, et al., “Initial magnetic resonance imaging volumetric brain measurements and outcome in schizophrenia: a prospective longitudinal study with 5-year follow-up,” Biol. Psychiat., 54, No. 6, 608–615 (2003).PubMedCrossRefGoogle Scholar
  42. 42.
    S. Mohamed, J. S. Paulsen, D. O’Leary, et al., “Generalized cognitive deficits in schizophrenia: a study of first-episode patients,” Arch. Gen. Psychiat., 56, 749–754 (1999).PubMedCrossRefGoogle Scholar
  43. 43.
    R. Näätänen and T. Picton, “The N1 wave of the human electric and magnetic response to sound: a review and an analysis of the component structure,” Psychophysiology, 24, No. 4, 375–425 (1987).PubMedCrossRefGoogle Scholar
  44. 44.
    P. Napoulos, L. Flashman, M. Flaum, et al., “Stability of cognitive functioning early in the course of schizophrenia,” Schizophrenia Res., 14, 29–37 (1994).CrossRefGoogle Scholar
  45. 45.
    R. Oades, D. Zerbin, A. Dittman-Balcar, and C. Eggers, “Auditory event-related potential (ERP) and difference-wave topography in schizophrenic patients with/without active hallucinations and delusions: a comparison with young obsessive-compulsive disorder (OCD) and healthy subjects,” Int. J. Psychophysiol., 22, No. 3, 185–214 (1996).PubMedCrossRefGoogle Scholar
  46. 46.
    B. O’Donnell, M. Shenton, R. McCarley, et al., “The auditory N2 component in schizophrenia: Relationship to MRI temporal lobe gray matter and to other ERP abnormalities,” Biol. Psychiat., 34, 26–40 (1993).PubMedCrossRefGoogle Scholar
  47. 47.
    C. Papageorgiou, P. Oulis, C. Vasios, et al., “P300 alterations in schizophrenic patients experiencing auditory hallucinations,” Eur. Neuropsychopharmacol., 14, No. 3, 227–236 (2004).PubMedCrossRefGoogle Scholar
  48. 48.
    J. Polich, “P300 in clinical application,” in: Electroencephalography. Basic Principles, Clinical Applications, and Related Fields, Williams & Wilkins, A Waverly Company, New York (1999), 4th Edition, pp. 1073–1085.Google Scholar
  49. 49.
    A. Reichenberg, “Cognitive impairment as a risk factor for psychosis,” in: Dialogues in Clinical Neuroscience. Early Stages of Schizophrenia (2005), Vol. 7, No. 1, pp. 31–38.Google Scholar
  50. 50.
    D. Robinson, M. G. Woerner, J. M. Alvir, et al., “Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder,” Arch. Gen Psychiat., 56, 241–247 (1999).PubMedCrossRefGoogle Scholar
  51. 51.
    V. Rotenberg, “An integrative psychophysiological approach to brain hemisphere functions in schizophrenia,” Neurosci. Biobehav. Rev., 18, No. 4, 487–495 (1994).PubMedCrossRefGoogle Scholar
  52. 52.
    D. Salisbury, M. Shenton, and A. Sherwood, “First-episode schizophrenic psychosis differs from first-episode affective psychosis and controls in P300 amplitude over left temporal lobe,” Arch. Gen. Psychiat., 55, No. 2, 173–180 (1998).PubMedCrossRefGoogle Scholar
  53. 53.
    J. Shapleske, S. Rossell, A. Simmons, et al., “Are auditory hallucinations the consequence of abnormal cerebral lateralization? A morphometric MRI study of the sylvian fissure and planum temporale,” Biol. Psychiat., 49, No. 8, 685–693 (2001).PubMedCrossRefGoogle Scholar
  54. 54.
    B. Turetsky, E. Colbath, and R. Gur, “P300 subcomponent abnormalities in schizophrenia: 11. Longitudinal stability and relationship to symptom change,” Biol. Psychiat., 43, 31–39 (1998).PubMedCrossRefGoogle Scholar
  55. 55.
    D. Umbricht, J. Bates, J. Lieberman, et al., “Electrophysiological indices of automatic and controlled auditory information processing in first-episode, recent-onset and chronic schizophrenia,” Biol. Psychiat., 59, No. 8, 762–772 (2006).PubMedCrossRefGoogle Scholar
  56. 56.
    O. van der Stelt, J. Lieberman, and A. Belger, “Auditory P300 in high-risk, recent-onset and chronic schizophrenia,” Schizophrenia Res., 77, No. 2–3, 309–320 (2005).Google Scholar
  57. 57.
    B. van Sweden, M. van Erp, and F. M. N. Mesotten, “Verbaten auditory information processing in schizophrenia: Subtype differences,” EEG Clin. Neurophysiol., 99, No. 4, 360 (1996).Google Scholar
  58. 58.
    A. Vita, L. De Peri, C. Silenzi, and M. Dieci, “Brain morphology in first-episode schizophrenia: A meta-analysis of quantitative magnetic resonance imaging studies,” Schizophrenia Res., 82, No. 1, 75–88 (2006).CrossRefGoogle Scholar
  59. 59.
    R. J. Wyatt, M. F. Green, and A. H. Tuma, “Long-term morbidity associated with delayed treatment of first admission schizophrenic patients: a re-analysis of the Camarillo State Hospital data,” Psychol. Med., 27, 261–268 (1997).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2008

Authors and Affiliations

  • I. S. Lebedeva
    • 1
  • V. G. Kaleda
    • 1
  • A. N. Barkhatova
    • 1
  1. 1.Scientific Center for Mental HealthRussian Academy of Medical SciencesMoscow

Personalised recommendations